Efficacy and Tolerability of Adjuvant Oral Capecitabine plus Intravenous Oxaliplatin (XELOX) in Asian Patients with Colorectal Cancer: 4-Year Analysis - Concepedia

Concepedia

Publication | Open Access

Efficacy and Tolerability of Adjuvant Oral Capecitabine plus Intravenous Oxaliplatin (XELOX) in Asian Patients with Colorectal Cancer: 4-Year Analysis

DOI Full Paper Access

21

Citations

14

References

2013

Year

Joanne Wing Yan Chiu, Vikki Tang, Roland Leung, Hilda Wong, Kin Wah Chu, Jensen T. C. Poon, Richard J. Epstein, Thomas Yau

Asian Pacific Journal of Cancer Prevention

Abstract

These results confirm the favourable long term survival benefit with good tolerability in using adjuvant XELOX in treating East Asian colorectal cancer patients.

References

	Year	Citations

Page 1